Key result
Transfer factor linked to transient clinical and immune improvement in disseminated varicella before fatal septicaemia.
Why the study?
Does transfer factor improve clinical outcomes and immune response in a patient with disseminated varicella infection complicating Hodgkin's disease?
Case Report (n=1)
Does transfer factor improve clinical outcomes and immune response in a patient with disseminated varicella infection complicating Hodgkin's disease?
Answers are grounded in this paper and cite their sources.
Transfer factor may provide transient clinical improvement and restore immune response in patients with disseminated varicella infection complicating Hodgkin's disease.
Treatment with transfer factor in a patient with disseminated varicella infection complicating stage IV Hodgkin's disease is described. The patient, a 24-year-old woman, showed transient clinical improvement and restoration of immune response to varicella-zoster antigen after receiving transfer factor. Though she later died from septicaemia, further trials of treatment of disseminated viral infection in patients with Hodgkin's disease with transfer factor are indicated.
No takes yet. Share an insight, caveat, or question.
A 1977 study conducted a case report in Disseminated varicella infection complicating stage IV Hodgkin's disease (n=1). Transfer factor was evaluated on Clinical improvement and immune response. Treatment with transfer factor in a 24-year-old woman with disseminated varicella and Hodgkin's disease led to transient clinical improvement and restored immune response, though she died of septicaemia.
Synapse has enriched 10 related papers. Consider them for comparative context: